Statin administration before percutaneous coronary intervention

Carlo Briguori, Antonio Colombo, Flavio Airoldi, Walter Longanella, Bruno Ricciardelli

Research output: Contribution to journalArticle

Abstract

We conducted a study to determine whether taking HMG-CoA reductase inhibitors (statins) before percutaneous coronary intervention (PCI) would prevent an increase in cardiac enzyme levels after the procedure. Results showed that statin treatment reduced the rate of increased cardiac enzyme levels and therefore periprocedural cardiac injury following PCI.

Original languageEnglish
Pages (from-to)18-21
Number of pages4
JournalCardiology Review
Volume22
Issue number12
Publication statusPublished - Dec 2005

    Fingerprint

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Briguori, C., Colombo, A., Airoldi, F., Longanella, W., & Ricciardelli, B. (2005). Statin administration before percutaneous coronary intervention. Cardiology Review, 22(12), 18-21.